169 related articles for article (PubMed ID: 28672194)
1. Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma.
Brüggemann M; Gromes A; Poss M; Schmidt D; Klümper N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC; Ellinger J
Transl Oncol; 2017 Aug; 10(4):661-668. PubMed ID: 28672194
[TBL] [Abstract][Full Text] [Related]
2. Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.
Ellinger J; Poss M; Brüggemann M; Gromes A; Schmidt D; Ellinger N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC
Clin Genitourin Cancer; 2017 Aug; 15(4):e551-e562. PubMed ID: 28063846
[TBL] [Abstract][Full Text] [Related]
3. Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.
Ellinger J; Gromes A; Poss M; Brüggemann M; Schmidt D; Ellinger N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC
Oncotarget; 2016 Dec; 7(52):86490-86499. PubMed ID: 27845902
[TBL] [Abstract][Full Text] [Related]
4. Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Stein J; Tenbrock J; Kristiansen G; Müller SC; Ellinger J
Int J Urol; 2019 Sep; 26(9):910-916. PubMed ID: 31280487
[TBL] [Abstract][Full Text] [Related]
5. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co‑expression analysis.
Yuan L; Chen L; Qian K; Wang G; Lu M; Qian G; Cao X; Jiang W; Xiao Y; Wang X
Oncol Rep; 2018 Feb; 39(2):525-536. PubMed ID: 29207195
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of mRNA expression level of the ATP synthase membrane subunit c locus 1 (
Saleh AA; Elhelbawy NG; Azmy RM; Abdelshafy MS; Donia SS; Abd El Gayed EM
Biochem Biophys Rep; 2022 Jul; 30():101234. PubMed ID: 35243015
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
11. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
[TBL] [Abstract][Full Text] [Related]
12. YRNA Expression Profiles are Altered in Clear Cell Renal Cell Carcinoma.
Nientiedt M; Schmidt D; Kristiansen G; Müller SC; Ellinger J
Eur Urol Focus; 2018 Mar; 4(2):260-266. PubMed ID: 28753785
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA lnc-ZNF180-2 is a prognostic biomarker in patients with clear cell renal cell carcinoma.
Ellinger J; Alam J; Rothenburg J; Deng M; Schmidt D; Syring I; Miersch H; Perner S; Müller SC
Am J Cancer Res; 2015; 5(9):2799-807. PubMed ID: 26609485
[TBL] [Abstract][Full Text] [Related]
14. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
16. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
17. ATP synthase subunit-β down-regulation aggravates diabetic nephropathy.
Guan SS; Sheu ML; Wu CT; Chiang CK; Liu SH
Sci Rep; 2015 Oct; 5():14561. PubMed ID: 26449648
[TBL] [Abstract][Full Text] [Related]
18. Rat mitochondrial ATP synthase ATP5G3: cloning and upregulation in pancreas after chronic ethanol feeding.
Li HS; Zhang JY; Thompson BS; Deng XY; Ford ME; Wood PG; Stolz DB; Eagon PK; Whitcomb DC
Physiol Genomics; 2001 Jul; 6(2):91-8. PubMed ID: 11459924
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
